We have located links that may give you full text access.
Inflammation and micronutrient deficiency as major risk factors for anemia in children with intestinal failure.
JPEN. Journal of Parenteral and Enteral Nutrition 2023 January 21
BACKGROUND: Most data on anemia in children with intestinal failure (IF) have been obtained from studies in which the data were collected at a single point in time. We aimed to identify the frequency of anemia and factors associated with hemoglobin levels in children with IF during their course of home parenteral nutrition.
METHODS: This prospective cohort study included patients with IF followed up at a pediatric intestinal rehabilitation center. Outcome variables were hemoglobin levels and prevalence of anemia during the follow-up period. The exposure variables were age, duration of parenteral nutrition, chronic disease, and serum concentrations of C-reactive protein, iron, copper, selenium, vitamins A, D, B12, and folic acid.
RESULTS: Twenty-five children with a median time receiving parenteral nutrition of 40.7 months were included. A median (IQR) of 40.7 (25.2; 58) hemoglobin measurements were performed per patient. Mean (SD) hemoglobin was 10.7 (1.8) g/dL at baseline and 11.6 (0.9) g/dL in the last observation (paired t-test, p=0.07); 32% of patients had mean hemoglobin values below the lower limit for age. In a multivariable predictive model, having C-reactive > 1 mg/dL was associated with a decrease of 0.57g/dL in hemoglobin (95% confidence interval [CI], -0.90; -0.24, p=0.01), and an increase of 1 mg/mL in serum vitamin A concentration represented an increase of 0.93 g/dL in hemoglobin level (95% CI, 0.24; 1.61, p=0.008).
CONCLUSION: Anemia affects almost one-third of children with IF and its frequency decreases during the follow-up period. Hemoglobin levels are associated with inflammatory response and serum micronutrient concentrations. This article is protected by copyright. All rights reserved.
METHODS: This prospective cohort study included patients with IF followed up at a pediatric intestinal rehabilitation center. Outcome variables were hemoglobin levels and prevalence of anemia during the follow-up period. The exposure variables were age, duration of parenteral nutrition, chronic disease, and serum concentrations of C-reactive protein, iron, copper, selenium, vitamins A, D, B12, and folic acid.
RESULTS: Twenty-five children with a median time receiving parenteral nutrition of 40.7 months were included. A median (IQR) of 40.7 (25.2; 58) hemoglobin measurements were performed per patient. Mean (SD) hemoglobin was 10.7 (1.8) g/dL at baseline and 11.6 (0.9) g/dL in the last observation (paired t-test, p=0.07); 32% of patients had mean hemoglobin values below the lower limit for age. In a multivariable predictive model, having C-reactive > 1 mg/dL was associated with a decrease of 0.57g/dL in hemoglobin (95% confidence interval [CI], -0.90; -0.24, p=0.01), and an increase of 1 mg/mL in serum vitamin A concentration represented an increase of 0.93 g/dL in hemoglobin level (95% CI, 0.24; 1.61, p=0.008).
CONCLUSION: Anemia affects almost one-third of children with IF and its frequency decreases during the follow-up period. Hemoglobin levels are associated with inflammatory response and serum micronutrient concentrations. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app